{
  "paper_metadata": {
    "pmid": "21092294",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the methylation patterns and polymorphisms in the BRCA2 gene in relation to sporadic breast cancer, identifying a specific polymorphism and its association with disease susceptibility."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.-26G>A",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 81,
        "demographics": "female patients aged 25 to 77 years, median age 48 years",
        "phenotype": "sporadic breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The study indicates that the BRCA2 -26 G/A 5'UTR polymorphism is associated with susceptibility to sporadic breast tumors.",
        "assays": []
      },
      "segregation_data": "The polymorphism was observed in the context of methylation patterns but specific segregation data was not provided.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the potential role of BRCA2 methylation in breast cancer development.",
      "key_quotes": [
        "The observation of BRCA2 -26 G/A 5'UTR polymorphism concomitant with the presence of methylation in the promoter region was novel and emerged as a strong candidate for susceptibility to sporadic breast tumors."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper specifically mentioned a variant in the BRCA2 gene."
  }
}